Evaluation of published reports of foam sclerotherapy: what do we know conclusively?

被引:13
作者
Myers, K. A. [1 ]
Roberts, S. [1 ]
机构
[1] Victoria Vein Clin, Melbourne, Vic, Australia
关键词
foam sclerotherapy; varicose; veins; reticular; telangiectases; GREAT SAPHENOUS-VEIN; ULTRASOUND-GUIDED SCLEROTHERAPY; RANDOMIZED CONTROLLED-TRIAL; POLIDOCANOL FOAM; VARICOSE-VEINS; ENDOVENOUS LASER; DETERGENT SCLEROSANTS; EFFICACY; MICROEMBOLISM; STABILITY;
D O I
10.1258/phleb.2009.009048
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: The aim was to evaluate the published literature to assess what is conclusively known about optimal technique and outcome for foam sclerotherapy. Methods: A literature search was performed for randomised controlled trials, meta-analyses and observational studies using appropriate statistical techniques with survival analysis for long-term outcome. Results: Foam is more effective than liquid for ultrasound-guided sclerotherapy. Both sclerosants commonly used are equally effective for sclerotherapy for small veins. Ultrasound signals appear in the systemic circulation in most patients after foam sclerotherapy but do not appear to be associated with serious complications. Conclusion: Little else is known about the optimal preparation of foamed sclerosants and the best technique for administering foam for sclerotherapy. Long-term studies are required to determine outcome for various techniques. There is an opportunity for many controlled trials to assess results.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [31] Diets for inflammatory bowel disease: What do we know so far?
    Serrano-Moreno, Clara
    Brox-Torrecilla, Noemi
    Arhip, Loredana
    Romero, Inmaculada
    Morales, Angela
    Luisa Carrascal, M.
    Cuerda, Cristina
    Motilla, Marta
    Camblor, Miguel
    Velasco, Cristina
    Breton, Irene
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2022, 76 (09) : 1222 - 1233
  • [32] What do we know about coaching in medical education? A literature review
    Lovell, Ben
    MEDICAL EDUCATION, 2018, 52 (04) : 376 - 390
  • [33] Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?
    Boccia, Serena Maria
    Sassu, Carolina Maria
    Ergasti, Raffaella
    Vertechy, Laura
    Apostol, Adriana Ionelia
    Palluzzi, Eleonora
    Fagotti, Anna
    Scambia, Giovanni
    Marchetti, Claudia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2021 - 2032
  • [34] Digital transformation, diversification and stability: What do we know about banks?
    Khattak, Mudeer Ahmed
    Ali, Mohsin
    Azmi, Wajahat
    Rizvi, Syed Aun R.
    ECONOMIC ANALYSIS AND POLICY, 2023, 78 : 122 - 132
  • [35] Cooperative banks: What do we know about competition and risk preferences?
    Clark, Ephraim
    Mare, Davide Salvatore
    Radic, Nemanja
    JOURNAL OF INTERNATIONAL FINANCIAL MARKETS INSTITUTIONS & MONEY, 2018, 52 : 90 - 101
  • [36] Chronic lateral epicondylopathy: What do we know about tennis elbow?
    Opitz, Gerhard
    ORTHOPADIE, 2025, 54 (04): : 302 - 308
  • [37] The Natural History of Retinal Vein Occlusion: What Do We Really Know?
    Decroos, Francis Char
    Fekrat, Sharon
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (05) : 739 - 741
  • [38] Psychological Mechanisms of Mindfulness-Based Interventions What Do We Know?
    Chiesa, Alberto
    Anselmi, Roberta
    Serretti, Alessandro
    HOLISTIC NURSING PRACTICE, 2014, 28 (02) : 124 - 148
  • [39] Targeting repetitive transcranial magnetic stimulation in depression: do we really know what we are stimulating and how best to do it?
    Fitzgerald, Paul B.
    BRAIN STIMULATION, 2021, 14 (03) : 730 - 736
  • [40] Deconstructing the Complexities of Advance Care Planning Outcomes: What Do We Know and Where Do We Go? A Scoping Review
    McMahan, Ryan D.
    Tellez, Ismael
    Sudore, Rebecca L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (01) : 234 - 244